# EDGAR Filing Document

**Accession Number:** 0001956744
**File Stem:** 0001641172-25-020966
**Filing Date:** 2025-7
**Character Count:** 18332
**Document Hash:** 3b64f8d7573ee64e5654d80038be6273
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-020966.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0001641172-25-020966

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tron Inc.
- **CENTRAL INDEX KEY:** 0001956744
- **STANDARD INDUSTRIAL CLASSIFICATION:** GAMES, TOYS & CHILDREN'S VEHICLES (NO DOLLS & BICYCLES) [3944]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 320686534
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94144
- **FILM NUMBER:** 251150779

**BUSINESS ADDRESS:**
- **STREET 1:** 941 W. MORSE BLVD.
- **STREET 2:** SUITE 100
- **CITY:** WINTER PARK
- **STATE:** FL
- **ZIP:** 32789
- **BUSINESS PHONE:** 407-230-8100

**MAIL ADDRESS:**
- **STREET 1:** 941 W. MORSE BLVD.
- **STREET 2:** SUITE 100
- **CITY:** WINTER PARK
- **STATE:** FL
- **ZIP:** 32789

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SRM Entertainment, Inc.
- **DATE OF NAME CHANGE:** 20221201
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bravemorning Ltd
- **CENTRAL INDEX KEY:** 0002075159

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** SEA MEADOW HOUSE
- **STREET 2:** PO BOX 116
- **CITY:** ROAD TOWN, TORTOLA
- **PROVINCE COUNTRY:** D8
- **ZIP:** 00000
- **BUSINESS PHONE:** 852-6999-3859

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** SEA MEADOW HOUSE
- **STREET 2:** PO BOX 116
- **CITY:** ROAD TOWN, TORTOLA
- **PROVINCE COUNTRY:** D8
- **ZIP:** 00000

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Tron Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**85237B101**

*(CUSIP Number)*

**Lawrence Venick, Esq.**<br>Loeb & Loeb LLP<br>10100 Santa Monica Blvd #2200<br>Los Angeles CA 90067<br>1 310 7285129

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**06/16/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **85237B101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bravemorning Limited** | Name of reporting person<br>**Bravemorning Limited** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**D8** | Citizenship or place of organization<br>**D8** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**420000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**420000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**420000000.00** | Aggregate amount beneficially owned by each reporting person<br>**420000000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**95.93%** | Percent of class represented by amount in Row (11)<br>**95.93%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Comment for Reporting Person:** For rows 7, 9 and 11, represents (A) 100,000 shares of Series B Preferred Stock held by Bravemorning Limited, with each such Preferred Stock Share having a stated value of $1,000.00 per share and in the aggregate being convertible into 200,000,000 shares of Common Stock at a conversion price of $0.50 per share plus (B) Warrants held by Bravemorning exercisable into 220,000,000 shares of Common Stock. For row 13, calculation based on 437,833,610 shares of Common Stock, which includes (i) 17,833,610 shares of Common Stock outstanding as of June 16, 2025 as disclosed by the Issuer in the Securities Purchase Agreement, (ii) 200,000,000 shares of Common Stock into which the 100,000 shares of Series B Preferred Stock issued by the Issuer to Bravemorning pursuant to the Securities Purchase Agreement are convertible, and (iii) 220,000,000 shares of Common Stock into which the Warrants issued by the Issuer to Bravemorning are exercisable. The underlying shares into which the Series B Preferred Stock is convertible and the Warrants are exercisable have been included in the calculation of the percentage set forth in row 13, notwithstanding that the Series B Preferred Stock has not been converted and the Warrants have not been exercised. The Preferred Stock Shares cannot be converted into more than 19.99% of the currently outstanding shares of Common Stock until stockholder approval of such an issuance is obtained and effective. In addition, no Reporting Person may vote any of shares of Series B Preferred Stock on an "as converted basis" that would be in excess of the Nasdaq threshold of 19.99% of the total voting power of the Issuer's outstanding securities until stockholder approval of the transaction is obtained and effective.

| **CUSIP No.** | **85237B101** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Weike Sun** | Name of reporting person<br>**Weike Sun** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**U7** | Citizenship or place of organization<br>**U7** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**420000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**420000000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**420000000.00** | Aggregate amount beneficially owned by each reporting person<br>**420000000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**95.93%** | Percent of class represented by amount in Row (11)<br>**95.93%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** For rows 7, 9 and 11, represents (A) 100,000 shares of Series B Preferred Stock held by Bravemorning Limited, with each such Preferred Stock Share having a stated value of $1,000.00 per share and in the aggregate being convertible into 200,000,000 shares of Common Stock at a conversion price of $0.50 per share plus (B) Warrants held by Bravemorning exercisable into 220,000,000 shares of Common Stock. For row 13, calculation based on 437,833,610 shares of Common Stock, which includes (i) 17,833,610 shares of Common Stock outstanding as of June 16, 2025 as disclosed by the Issuer in the Securities Purchase Agreement, (ii) 200,000,000 shares of Common Stock into which the 100,000 shares of Series B Preferred Stock issued by the Issuer to Bravemorning pursuant to the Securities Purchase Agreement are convertible, and (iii) 220,000,000 shares of Common Stock into which the Warrants issued by the Issuer to Bravemorning are exercisable. The underlying shares into which the Series B Preferred Stock is convertible and the Warrants are exercisable have been included in the calculation of the percentage set forth in row 13, notwithstanding that the Series B Preferred Stock has not been converted and the Warrants have not been exercised. The Preferred Stock Shares cannot be converted into more than 19.99% of the currently outstanding shares of Common Stock until stockholder approval of such an issuance is obtained and effective. In addition, no Reporting Person may vote any of shares of Series B Preferred Stock on an "as converted basis" that would be in excess of the Nasdaq threshold of 19.99% of the total voting power of the Issuer's outstanding securities until stockholder approval of the transaction is obtained and effective.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Tron Inc.

**(c) Address of Issuer's Principal Executive Offices:**
941 W. MORSE BLVD., SUITE 100, WINTER PARK, FL, 32789

Bravemorning Limited has acquired (A) preferred stock which is convertible into 200,000,000 shares of common stock and (B) warrants to purchase 220,000,000 shares of common stock

**Item 4. Purpose of Transaction**

The information set forth in Items 3 and 6 of this Schedule 13D is hereby incorporated by reference into this Item 4. The Reporting Persons acquired the securities reported herein for the purposes of obtaining control of the Issuer. In connection with the transactions, (A) Hans Haywood and Gary Herman resigned as members of the Board; (B) Douglas McKinnon resigned as a member of the Board (Mr. McKinnon remains the Company's Chief Financial Officer. Mr. McKinnon's resignation as a member of the Board was not a result of any disagreements with the Company on any matter relating to the Company's operations, policies, or practices) and (C) Mr. Weike Sun, Zhihong Liu ("Mr. Liu"), and Zi Yang ("Mr. Yang") were appointed as members of the Board. Mr. Weike Sun was named Chairman of the Board. Mr. Liu and Mr. Yang are appointed to each of the Audit, Compensation, and Nominating and Corporate Governance Committees of the Board. Mr. Liu is expected to serve as chair of the Compensation Committee and Mr. Yang is expected to serve as chair of the Nominating and Corporate Governance Committee. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and, subject to the terms and conditions of the Securities Purchase Agreement, may, from time to time, and at any time in the future, formulate plans or proposals depending on various factors, including the Issuer's financial position and strategic direction, corporate transactions, actions taken by the Issuer's Board of Directors, price levels of the Issuer's securities, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, and take such actions with respect to the investment in the Issuer as they deem appropriate, including changing their current intentions, with respect to any or all matters required to be disclosed in this Schedule 13D. Without limiting the foregoing and the subject to any transfer restrictions set forth in the Securities Purchase Agreement, the Reporting Persons may, from time to time, (i) acquire additional shares of Common Stock, other equity, debt, notes, other securities, or derivative, other instruments that are based upon or relate to the value of securities of the Issuer or any combination of the foregoing (collectively, the "Securities") in the open market, private transactions or otherwise; (ii) dispose of any or all of their Securities in the open market, private transactions or otherwise, including pursuant to registered transactions if and when such registered transactions are approved by the Issuer; (iii) engage in any hedging, derivative or similar transactions, including with respect to the Securities or otherwise; (iv) discuss with the Issuer's management, including the Board, the governance and strategic direction of the Issuer; or (v) propose or consider one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D. The Series B Preferred Stock Shares cannot be converted into more than 19.99% of the currently outstanding shares of Common Stock until stockholder approval of such an issuance is obtained and effective. In addition, no Reporting Person may vote any of shares of Series B Preferred Stock on an "as converted basis" that would be in excess of the Nasdaq threshold of 19.99% of the total voting power of the Issuer's outstanding securities until such stockholder approval is obtained and effective. The Reporting Persons undertake no obligation to make additional disclosures except to the extent required by law.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information set forth in the cover pages and Item 2 of this Schedule 13D is hereby incorporated by reference into this Item 5. The Reporting Persons beneficially own 100,000 shares of Series B Preferred Stock (convertible into an aggregate of 200,000,000 shares of Common Stock) and Warrants to purchase 220,000,000 shares of Common Stock, as of the close of business on June 16, 2025. Each share of Series B Preferred Stock has identical voting rights as the number of shares of Common Stock into which per Series B Preferred Stock are convertible. The holding of the Series B Preferred Stock and the Common Stock exercised from the Warrants owned by the Reporting Persons constitutes approximately [95.93%] of the voting power of the Common Stock. This percentage is based on (i) 17,833,610 shares of Common Stock outstanding as of June 16, 2025 as disclosed by the Issuer in the Securities Purchase Agreement, (ii) 200,000,000 shares of Common Stock into which the 100,000 shares of Series B Preferred Stock issued by the Issuer to Bravemorning pursuant to the Securities Purchase Agreement are convertible, and (iii) 220,000,000 shares of Common Stock into which the Warrants issued by the Issuer to Bravemorning are exercisable. The Series B Preferred Stock Shares cannot be converted into more than 19.99% of the currently outstanding shares of Common Stock until stockholder approval of such an issuance is obtained and effective. In addition, no Reporting Person may vote any of shares of Series B Preferred Stock on an "as converted basis" that would be in excess of the Nasdaq threshold of 19.99% of the total voting power of the Issuer's outstanding securities until such stockholder approval is obtained and effective. The Reporting Persons do not beneficially own any shares of Common Stock except as described herein.

**(b)**
Bravemorning is the direct beneficial owner, and has sole power to vote and direct the disposition, of 100,000 shares of Series B Preferred Stock (which are convertible into 200,000,000 shares of Common Stock) and Warrants to purchase 220,000,000 shares of Common Stock, as of the close of business on June 16, 2025. Mr. Weike Sun is the indirect beneficial owner of such shares of Series B Preferred Stock and such Warrants. As such, Mr. Weike Sun has sole power to vote and direct the disposition of such shares of Series B Preferred Stock and such Warrants.

**(c)**
The Reporting Persons have not engaged in any transaction in any shares of Common Stock during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

On June 16, 2025, the Issuer entered into the Securities Purchase Agreement with Bravemorning. Pursuant to the Securities Purchase Agreement, on June 16, 2025, Bravemorning purchased from the Issuer 100,000 shares of Series B Preferred Stock and Warrants to purchase 220,000,000 shares of Common Stock for an aggregate purchase price of $100,000,000. The purchase of the Series B Preferred Stock and Warrants were paid in the form of TRX tokens on June 28, 2025; these tokens were derived from Bravemorning's TRX holdings. The Series B Preferred Stock Shares cannot be converted into more than 19.99% of the currently outstanding shares of Common Stock until stockholder approval of such an issuance is obtained and effective. In addition, no Reporting Person may vote any of shares of Series B Preferred Stock on an "as converted basis" that would be in excess of the Nasdaq threshold of 19.99% of the total voting power of the Issuer's outstanding securities until such stockholder approval is obtained and effective.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bravemorning Limited

**Signature:** /s/ Weike Sun

**Name/Title:** Bravemorning Limited, by Mr. Weike Sun, its Director

**Date:** 07/24/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Weike Sun

**Signature:** /s/ Weike Sun

**Name/Title:** Mr. Weike Sun

**Date:** 07/24/2025